Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates
aInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing 100050, China
bInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing 100005, China
cXinjiang Key Laboratory of Uygur Medical Research, Xinjiang Institute of Materia Medica, Urumqi 830004, China
dRinuaGene Biotechnology Co., Ltd., Suzhou 215127, China
eInstitute of Medical Biology, Chinese Academy of Medical Sciences, Kunming 650118, China
fInstitute of Laboratory Animals Science, Chinese Academy of Medical Sciences, Beijing 100021, China
* Corresponding authors.
收起